What do systematic reviews say?

Rivastigmine vs placebo

• Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta‐analysis 2021 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 748 participants
  Low